Advancing the Future of Oncology As the global biotech community prepares for the upcoming BIO-Europe 2026 conference, ImmunoForge has announced its intention to showcase significant advancements in its therapeutic portfolio. The company is set to present its proprietary platform technologies and share critical updates regarding its next-generation oncology research and development efforts. Focusing on Clinical…